Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity
[PR Newswire] – ROCKVILLE, Md., Feb. 13, 2014 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of product candidates focused on the prevention and treatment of serious infectious and other diseases, announced today that in view of t moreView todays social media effects on SYNView the latest stocks trending across Twitter. Click to view dashboardSee who Synthetic is […]
